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TNF-a-induced insulin resistance is associated with generation of reactive oxygen species (ROS). This
study aims at deﬁning the link between ROS production and hepatic insulin resistance. Treatment
with TNF-a increased ROS generation through activating NADPH oxidase 3 (NOX3) in HepG2 hepa-
tocytes. Down-regulation of NOX3 using siRNA prevented TNF-a-induced decrease of cellular glyco-
gen. In the cells treated with TNF-a, there were NOX3-dependent activation of JNK, inhibition of IRS1
and phosphorylation of AKT/PKB and GSK. In conclusion, the effects of TNF-a on hepatic insulin
resistance appear to be, at least in part, mediated by NOX3-derived ROS through a JNK pathway.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction which may induce various signaling pathways including p38MAPK,Insulin resistance, deﬁned as a diminished ability of cells such
as adipocytes, skeletal muscle cells and hepatocytes to respond
to the action of insulin, is a key feature of type 2 diabetes. In hepa-
tocytes, insulin resistance is brought about by a combination of
pathological alterations: hyperglycaemia, hyperinsulinaemia, oxi-
dative stress and altered proﬁles of adipocytokines.
A large body of evidence shows that oxidative stress, generated
through increased generation of reactive oxygen species (ROS), can
be observed in insulin resistant cells and tissues [1]. The enhanced
ROS production is thought to lead to abnormal intracellular signal-
ing and thereby causally contribute to the development insulin
resistance [2]. Decreased glycogen levels are a hallmark of insulin-
resistant hepatocytes; underlying mechanisms include decreased
glycogen synthesis and failure to suppress glucose production [3].
TNF-a has been recognized as an important mediator of insulin
resistance by impairing insulin signaling [4]. Moreover, it has been
well demonstrated that TNF-a may lead to increased ROS levels,chemical Societies. Published by E
receptor substrate; JNK, Jun
ethyl ester; NOX, NADPH
ence; ROS, reactive oxygen
ian@bjhmoh.cn (J. Li).ERK and JNK activation. However, little is known about the cellular
mechanisms of ROS generation in TNF-a-induced hepatic insulin
resistance and the link between ROS and hepatic insulin resistance.
ROS are produced via multiple processes such as mitochondrial
electron transport chain, nitric oxide synthase, xanthine oxidase, as
well as NOX family NADPH oxidases [5]. Recent attention has been
focused on NOX enzymes as a potential source of ROS production
in insulin resistance [6]. The NOX family consists of several mem-
bers, with distinct cellular and subcellular distribution, as well as
distinct cellular functions [7]. A role for NOX3 in insulin action in
hepatocytes has been suggested [8].
Here, we test the hypothesis that NOX3-derived ROS mediate
the TNF-a effect on hepatocytes, particularly the drop in cellular
glycogen content. We provide evidence that the effects of TNF-a
appear to be, at least in part, mediated by NOX3-derived ROS
through a JNK pathway.
2. Materials and methods
2.1. Analysis of cellular glycogen content
Glycogen levels were measured in cells incubated for 3 h in the
presence of 1 nmol/l insulin (Usbio) using a glycogen assay kit
(Biovision).lsevier B.V. All rights reserved.
Fig. 1. Analysis of insulin sensitivity, plasma TNF-a, intracellular glycogen, and ROS
in rats on high-fat diet. Rats were on a high fat diet and insulin sensitivity index (ISI)
(ln[1/(fasting blood glucose  fasting serum insulin)]) (A), plasma TNF-a levels (B),
liver intracellular glycogen content (C), and liver tissue ROS generation assessed by
DHE ﬂuorescence (D) were determined. Data are presented as mean ± S.E.M., n = 6.
*P < 0.05 by ANOVA test.
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Cells (3  105 cells/ml) were incubated with 5 lmol/l of DCF-DA
(Sigma) for 40 min at 37 C. The DCF ﬂuorescence was measured by
FACS.
The sections of OCT-embedded liver tissues were incubated
with 10 lmol/l DHE (Sigma) for 15 min at room temperature.
The sections were analyzed by ﬂuorescence microscopy.
2.3. RNA extraction, RT-PCR and real-time PCR
Extraction of total RNA (Trizol, Invitrogen), RT (A3500 kit, Pro-
mega), and real time PCR (7500 system, ABI) were performed
according to manufacturer’s instruction.
2.4. Immunoﬂuorescence and immunohistochemistry
The coverslips of HepG2 or sections of OCT-embedded liver tis-
sues of rats were incubated with polyclonal antibodies at 37 C for
60 min then labeled with TRITC-conjugated anti-rabbit IgG at 37 C
for 60 min. Finally, the coverslips were mounted with DABCO.
2.5. siRNA transfection
The siRNA targeting NOX3 mRNA were transfected into HepG2
using Tran Messenger TM Transfection Reagent (Qiagen) according
to manufacture’s instruction.
2.6. Western blot
Cell lysates (30–60 lg protein) were separated by 10% SDS–
PAGE, transferred to PVDF membrane (Millipore), blocked with
5% non-fat dry milk, and probed with antibodies at 4 C overnight.
The blots were incubated with HRP-conjugated anti-IgG, followed
by detection with ECL (Santa Cruz).
2.7. Statistical analysis
All values are represented as means ± S.E.M. of the indicated
number of measurements. One-way ANOVA test was used to deter-
mine signiﬁcance, requiring P < 0.05 for statistical signiﬁcance.3. Results and discussions
TNF-a has been implicated in the pathogenesis of insulin resis-
tance in vitro and in vivo [9]. In the ﬁrst set of experiments, we fed
rats a high-fat diet to induce insulin resistance. After 12 weeks, the
rats weighed 20% more than control rats, but still maintained nor-
mal blood glucose levels (data not shown). However, plasma insu-
lin levels in the rats fed with high-fat diet were increased,
demonstrating decreased insulin sensitivity (Fig. 1A). Rats under
high-fat diet showed elevated plasma TNF-a level (Fig. 1B). Hepatic
glycogen levels in rats fed with high-fat diet were signiﬁcantly de-
creased, conﬁrming insulin resistance (Fig. 1C). ROS have been pro-
posed to play a causal role in insulin resistance [10]. ROS
measurement in hepatic tissue slices showed enhanced ROS pro-
duction in rats fed a high-fat diet (Fig. 1D). These observations
raised the possibility that ROS may be the link between TNF-a
and insulin resistance.
We next sought to extend these observations from an in vivo
model to a cellular model of insulin resistance. In cultured HepG2
cells, TNF-a has been suggested to induce insulin-resistance, as as-
sessed by their decreased capacity to accumulate glycogen in the
presence of insulin. To exclude the side effects associated to TNF-
a, such as apoptosis, we quantiﬁed the cell viability in TNF-a-trea-ted HepG2 by MTT assay. The results indicated no cytotoxicity in
connection with the time of exposure to TNF-a (4 ng/ml, 2–4 days)
(Fig. 2A) and the dose of TNF-a (2–6 ng/ml, 4 days) (Fig. 2B) in
HepG2. Indeed, TNF-a (4–6 ng/ml, 4 days) led to a dose-dependent
decreased glycogen content of HepG2 (Fig. 2C). We then investi-
gated whether ROS levels were altered by TNF-a treatment. As
shown in Fig. 2D, ROS levels were dose-dependently increased by
exposure of cells to TNF-a. To identify the source of ROS generated
in response to TNF-a, we studied the effects of different inhibitors
of ROS-generating systems: DPI (NOX NADPH oxidase, 5 lmol/l),
L-NAME (nitric oxide synthases, 100 lmol/l), rotenone (mitochon-
drial respiratory chain, 2 lmol/l) and oxypurinol (xanthine
oxidase, 100 lmol/l). Similarly, there was no cytotoxicity in inhib-
itors-treated HepG2 (Fig. 2E). However, only DPI inhibited the
generation of ROS in response to TNF-a (4 ng/ml, 4 days)
(Fig. 2F), raising the possibility that a NOX enzyme could be the
source of ROS.
We therefore analyzed the expression of NOX isoforms and sub-
units in non-treated and TNF-a-treated HepG2. Using RT-PCR, we
found expression of NOX3, but not NOX1, NOX2, NOX4 and
NOX5 in non-treated and TNF-a-treated HepG2, indicating that
TNF-a-induced ROS might be derived from NOX3 (Fig. 2G). We also
found p22phox, p67phox, p47phox and Rac1 (Fig. 2G). A similar
expression pattern of NOXs and partners was found in hepatic tis-
sues (data not shown). Previous studies have demonstrated the ab-
sence of NOXO1 and NOXA1 in HepG2 [8], raising the possibility
that p47phox might function as an activator subunit for NOX3 in
HepG2.
We next examined the effect of TNF-a treatment on expression
and activity of NOX3 in HepG2. Interestingly, TNF-a up-regulated
the expression of NOX3, but not p22phox, p47phox, p67phox and
Rac1 as shown in Fig. 3A. Importantly, the expression of NOX3
was not only enhanced in response to TNF-a in vitro, but also in
response to high fat diet in vivo (Fig. 3B). Protein kinase C (PKC)
regulates the activation NOX2, and may activate NOX3, at least
with p47phox as organizer subunit [11]. We therefore investigated
the role of PKC in TNF-a-induced ROS generation. PMA induced a
strong ROS generation, which was not enhanced by the addition
of TNF-a, suggesting that they act within the same pathway. The
PKC inhibitor hypericin (4 lmol/l, preincubation for 30 min) inhib-
ited TNF-a-induced ROS generation (Fig. 3D) but without cytotox-
icity (Fig. 3C). From the two known NOX activator subunits, only
p47phox, but not NOXO1 is expressed in HepG2 cells, raising the
Fig. 2. TNF-a-induced increased ROS generation through expression of NOX enzymes. No cytotoxicity in connection with the time of exposure to TNF-a (4 ng/ml, 2–4 days)
(A), and the dose of TNF-a (2–6 ng/ml,4 days) (B), in HepG2 cells as indicated by MTT assay. TNF-a (4–6 ng/ml, 4 days) decreased intracellular glycogen levels (C), and
stimulated ROS production detected by DCF (D), in a concentration-dependent manner. No cytotoxicity in inhibitors-treated HepG2 (E). DPI impaired TNF-a-induced ROS
generation (F). The mRNA expression proﬁle of NOX isoforms and subunits in non-treated and TNF-a-treated HepG2 (G). Data are presented as mean ± S.E.M., n = 3
independent experiments. *P and #P < 0.05 by ANOVA test.
Fig. 3. TNF-a-induced enhanced expression and activity of NOX3. Expression of NOX3 in HepG2 treated with 4 ng/ml TNF-a for 4 days (A) and livers of rats fed a high-fat diet
for 12 weeks (B). Effect of the PKC activator PMA (1 lmol/l) and the PKC inhibitor hypericin (4 lmol/l) on cell viability (C) and TNF-a-induced ROS generation in HepG2 (D).
Subcellular localization of p47phox in TNF-a-treated HepG2 cells, as measured by confocal immunoﬂuorescence microscopy and western blot (E and F). Impact of apocynin
on TNF-a-induced ROS generation (G). Data are presented as mean ± S.E.M., n = 3 independent experiments. *P < 0.05 compared with control and #P < 0.05 compared with
TNF-a treatment by ANOVA test.
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tion of NOX3. In unstimulated cells, p47phox exist in the cytosol,
while upon stimulation it translocates to the plasma membrane
[12]. We have therefore investigated subcellular localization of
p47phox by confocal immunoﬂuorescence microscopy. As shownin Fig. 3E, p47phox had a cytoplasmic distribution in unstimulated
HepG2 cells, but showed a plasma membrane distribution in re-
sponse to TNF-a stimulation. Furthermore, membrane proteins
were extracted to conﬁrm TNF-a-induced membrane distribution
of p47phox (Fig. 3F). The antioxidant/NOX inhibitor apocycin has
998 L. Li et al. / FEBS Letters 584 (2010) 995–1000been suggested to act, in least in part, through inhibition of
p47phox translocation [5]. Fig. 3E and F demonstrate that apocynin
(100 lmol/l, 30 min) prevented TNF-a-induced p47phox translo-
cation. Apocynin also prevented the increase in ROS levels in re-
sponse to TNF-a (Fig. 3G). Taken together, the results
demonstrate that TNF-a enhanced the production of ROS through
two mechanisms: (i) increased NOX3 protein levels, and (ii) PKC-
dependent NOX3 activation, presumably involving p47phox
translocation.
To further explore the role of NOX3 in TNF-a-induced increased
ROS generation and decreased glycogen level in hepatocytes, we
transiently transfected siRNA targeting NOX3 (siRNA–NOX3) into
HepG2. Analysis by real-time PCR indicated that the amount of
NOX3 mRNA was markedly down-regulated both in control and
in TNF-a-treated cells, while control siRNA had no effect
(Fig. 4A). Similarly, NOX3 protein was reduced following siRNA–
NOX3 transfection both in control and TNF-a-treated cells
(Fig. 4B). NOX3 siRNA led to an approximately 50% decrease of ba-
sal ROS generation, but completely abolished TNF-a-induced ROS
generation (Fig. 4C). Thus, while several sources of ROS might par-
ticipate in basal ROS generation in HepG2 cells, it appears that
NOX3 is the predominant source of ROS induced by TNF-a. We
next investigated the role of NOX3 in the regulation of intracellular
glycogen levels (Fig. 4D). NOX3 siRNA did not impact glycogen lev-Fig. 4. Effects of NOX3 siRNA on TNF-a-induced alterations of ROS generation and ce
analyzed after 4 days. When indicated, cells were incubated on day 3 and 4 with TNF-a (4
cellular ROS generation (C), and cellular glycogen levels (D). Data are presented as meaels under control conditions, but completely prevented the TNF-a-
induced decrease of glycogen. These data demonstrate that NOX3-
derived ROS are essential mediators of the TNF-a-induced de-
creased glycogen levels in hepatocytes.
Finally, we investigated downstream pathways translating ele-
vated ROS levels into decreased glycogen levels. One attractive
possibility is that ROS-induced insulin resistance is mediated by
JNK. ROS promote activation of JNK [13] and JNK deletion or inhi-
bition improves insulin sensitivity in mice [14,15]. Our results
show that JNK was activated in response to TNF-a, and that effect
was reversed by NOX3 down-regulation (Fig. 5A). In parallel with
increased phosphorylation of JNK, TNF-a down-regulated levels
of IRS1 and stimulated its inhibitory phosphorylation on Ser307
(Fig. 5B). This corroborates previous studies [16]. Importantly,
the decreased IRS1 protein levels and the increased Ser307 phos-
phorylation were reversed by NOX3 siRNA, to a similar extend as
observed with SP600125 (Fig. 5B). Moreover, pretreatment with
SP600125 (JNK inhibitors) can reverse the decrease of cellular
glycogen levels induced by TNF-a (Fig. 5C). The TNF-a-induced
impaired phosphorylation of AKT and GSK was rescued by siRNA-
mediated NOX3 reduction (Fig. 5D and E). Thus, NOX3-derived ROS
play a key role in TNF-a signaling towards insulin resistance.
In conclusion, our data indicate a key role of NOX3-derived
ROS in TNF-a-induced insulin resistance in hepatocytes: (i) NOX3llular glycogen levels. HepG2 were transiently transfected with siRNA–NOX3 and
ng/ml). NOX3 mRNA levels detected by real-time PCR (A); NOX3 protein levels (B);
n ± S.E.M., n = 3 independent experiments. *P and #P < 0.05 by ANOVA test.
Fig. 5. Inﬂuences of NOX3 siRNA on TNF-a-induced alterations of signaling pathways. HepG2 were transiently transfected with siRNA–NOX3 and analyzed after 72 h. When
indicated, TNF-a (4 ng/ml) and/or the JNK inhibitor SP600125 (20 lmol/l) was included after 48 h. Western blots of total and phosphorylated protein are shown for JNK (A),
IRS1 (B), AKT/PKB (D), and GSK (E). The anti-phosphoIRS1 antibody recognized Ser307. Pretreatment with SP600125 for 30 min can reverse the decrease of cellular glycogen
levels induced by TNF-a (4 ng/ml, 48 h) (C). All experiments were performed in the presence of 1 nmol/l insulin. Data are presented as mean ± S.E.M., n = 3 independent
experiments. *P < 0.05 compared with control and #P < 0.05 compared with TNF-a treatment by ANOVA test.
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(ii) this ROS generation is critically involved in the alterations of
intracellular signaling associated with insulin resistance and in
the resulting decrease of intracellular glycogen levels.
The association of NOX3 and insulin resistance is not only ob-
served in the HepG2 cell line, but also observed in the liver of rats
fed with high fat diet. However, the relative importance of NOX3 as
source of ROS generating insulin resistance in vivo needs further
investigation. Also, the upregulation and activation of NOX3 by
TNF-a is of interest. In particular, our results suggest that PKC acti-
vation and p47phox translocation might activate NOX3 in hepato-
cytes, while in the inner ear, NOX3 appears to be associated with
NOXO1 as an activator subunit [11].
Redox activation of JNK is well known and likely to play a
role in the NOX3-dependent induction of insulin resistance: JNK
induces inhibitory serine-phosphorylation and degradation of
IRS-1, leading to diminished PI3-kinase activity and a subsequent
drop in AKT/PKB and GSK phosphorylation, ﬁnally resulting in
decreased glycogen synthesis [17]. However, further studies
are needed to determine whether NOX3 acts exclusively through
this pathway or whether additional signaling steps might be
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